These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28120182)

  • 1. Expression of YAP1 in aggressive thyroid cancer.
    Celano M; Mignogna C; Rosignolo F; Sponziello M; Iannone M; Lepore SM; Lombardo GE; Maggisano V; Verrienti A; Bulotta S; Durante C; Di Loreto C; Damante G; Russo D
    Endocrine; 2018 Jan; 59(1):209-212. PubMed ID: 28120182
    [No Abstract]   [Full Text] [Related]  

  • 2. miR‑205 targets YAP1 and inhibits proliferation and invasion in thyroid cancer cells.
    Li D; Wang Q; Li N; Zhang S
    Mol Med Rep; 2018 Aug; 18(2):1674-1681. PubMed ID: 29845281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment.
    Takami H; Ozaki O; Ito K
    Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma.
    Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL
    Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
    Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
    Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly differentiated carcinoma of the thyroid: an aggressive type of tumour arising from thyroid follicular epithelium.
    Sakamoto A
    Curr Top Pathol; 1997; 91():45-50. PubMed ID: 9018915
    [No Abstract]   [Full Text] [Related]  

  • 7. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of microsatellite in the thyroid hormone receptor-alpha1 gene linked to increased receptor expression and less aggressive thyroid cancer.
    Onda M; Li D; Suzuki S; Nakamura I; Takenoshita S; Brogren CH; Stampanoni S; Rampino N
    Clin Cancer Res; 2002 Sep; 8(9):2870-4. PubMed ID: 12231529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
    Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
    Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MicroRNAs in Thyroid Carcinoma.
    Zhu G; Xie L; Miller D
    Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
    Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
    Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.
    Todorović L; Stanojević B; Mandušić V; Petrović N; Živaljević V; Paunović I; Diklić A; Saenko V; Yamashita S
    Med Oncol; 2018 Jan; 35(2):17. PubMed ID: 29340905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
    Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Xu B; Serrette R; Tuttle RM; Alzumaili B; Ganly I; Katabi N; Tallini G; Ghossein R
    Thyroid; 2019 Dec; 29(12):1792-1803. PubMed ID: 31452453
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
    Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
    Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.